A detailed history of Dgs Capital Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Dgs Capital Management, LLC holds 13,491 shares of MRK stock, worth $1.32 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
13,491
Previous 12,773 5.62%
Holding current value
$1.32 Million
Previous $1.58 Million 3.1%
% of portfolio
0.43%
Previous 0.46%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 10, 2024

BUY
$111.15 - $128.97 $79,805 - $92,600
718 Added 5.62%
13,491 $1.53 Million
Q2 2024

Dec 10, 2024

BUY
$123.8 - $132.96 $328,317 - $352,609
2,652 Added 26.2%
12,773 $1.58 Million
Q1 2024

Apr 15, 2024

BUY
$113.24 - $131.95 $477,646 - $556,565
4,218 Added 71.46%
10,121 $1.34 Million
Q4 2023

Jan 30, 2024

SELL
$100.18 - $109.02 $57,403 - $62,468
-573 Reduced 8.85%
5,903 $643,000
Q3 2023

Jan 30, 2024

SELL
$102.95 - $114.33 $14,927 - $16,577
-145 Reduced 2.19%
6,476 $666,000
Q2 2023

Jan 30, 2024

BUY
$108.61 - $118.38 $52,132 - $56,822
480 Added 7.82%
6,621 $763,000
Q1 2023

Jun 16, 2023

BUY
$102.94 - $114.86 $720 - $804
7 Added 0.11%
6,141 $653,000
Q4 2022

Feb 21, 2023

BUY
$87.44 - $112.11 $46,343 - $59,418
530 Added 9.46%
6,134 $680,000
Q3 2022

Feb 21, 2023

BUY
$84.53 - $94.96 $66,609 - $74,828
788 Added 16.36%
5,604 $482,000
Q2 2022

Jul 28, 2022

BUY
$83.49 - $94.64 $110,373 - $125,114
1,322 Added 37.84%
4,816 $439,000
Q1 2022

May 05, 2022

BUY
$73.51 - $82.4 $38,813 - $43,507
528 Added 17.8%
3,494 $287,000
Q4 2021

Jan 28, 2022

BUY
$72.28 - $90.54 $214,382 - $268,541
2,966 New
2,966 $227,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Dgs Capital Management, LLC Portfolio

Follow Dgs Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dgs Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dgs Capital Management, LLC with notifications on news.